Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients – an economic evaluation

Vox Sanguinis

Volumn 111, Issue 3, 2016, Pages 292-298

  Okerberg, C K ^a   Williams, L A ^b   Kilgore, M L ^a   Kim, C H ^c   Marques, M B ^b   Schwartz, J ^d   Pham, H P ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Department of Medicine   (United States)

Author keywords

blood product; cost effectiveness; cryoprecipitate; fibrinogen concentrate; haemorrhage; plasma derivative; RiaSTAP ; transfusion

Indexed keywords

FIBRINOGEN CONCENTRATE; BLOOD CLOTTING FACTOR 8; CRYOPRECIPITATE COAGULUM; FIBRINOGEN;

ARTICLE; BLEEDING; CONTROLLED STUDY; CRYOPRECIPITATE; DRUG COST; ECONOMIC EVALUATION; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; ECONOMIC MODEL; ECONOMICS; HEMORRHAGE; QUESTIONNAIRE;

BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; FACTOR VIII; FIBRINOGEN; HEMORRHAGE; HUMANS; MODELS, ECONOMIC; SURVEYS AND QUESTIONNAIRES;

EID: 84973161243     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12417     Document Type: Article

References (29)

1. Levy JH, Szlam F, Tanaka KA, et al.: Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114:261–274
2. Yang L, Stanworth S, Baglin T: Cryoprecipitate: an outmoded treatment? Transfus Med 2012; 22:315–320
3. Hiippala ST, Myllyla GJ, Vahtera EM: Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360–365
4. Ciavarella D, Reed RL, Counts RB, et al.: Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67:365–368
5. Charbit B, Mandelbrot L, Samain E, et al, Group PPHS: The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5:266–273
6. Rourke C, Curry N, Khan S, et al.: Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342–1351
7. Ucar HI, Oc M, Tok M, et al.: Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. Heart Surg Forum 2007; 10:E392–E396
8. Pham HP, Shaz BH: Update on massive transfusion. Br J Anaesth 2013; 111(Suppl 1):i71–i82
9. Karlsson M, Ternstrom L, Hyllner M, et al.: Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008; 48:2152–2158
10. Levy JH, Goodnough LT: How I use fibrinogen replacement therapy in acquired bleeding. Blood 2015; 125:1387–1393
11. Levy JH, Welsby I, Goodnough LT: Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54:1389–1405; quiz 8.
12. Warmuth M, Mad P, Wild C: Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012; 56:539–548
13. Solomon C, Groner A, Ye J, et al.: Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data. Thromb Haemost 2015; 113:759–771
14. Sorensen B, Bevan D: A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149:834–843
15. Elliott BM, Aledort LM: Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate. Expert Rev Hematol 2013; 6:277–286
16. Collins PW, Solomon C, Sutor K, et al.: Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 2014; 113:585–595
17. Harvey AR, Basavaraju SV, Chung KW, et al.: Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion 2015; 55:709–718
18. Pereira A: Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica 2007; 92:846–849
19. Ahmed S, Harrity C, Johnson S, et al.: The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage–an observational study. Transfus Med 2012; 22:344–349
20. Spahn DR, Bouillon B, Cerny V, et al.: Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17:R76
21. Lunde J, Stensballe J, Wikkelso A, et al.: Fibrinogen concentrate for bleeding–a systematic review. Acta Anaesthesiol Scand 2014; 58:1061–1074
22. Pham HP, Kim CH, Schwartz J: Phenotypically matched vs. traditional screen method for preparing red blood cell units in patients with abnormal placentation: a decision analysis approach. Vox Sang 2014; 107:399–406
23. Johnson DW, Schmidt UH, Bittner EA, et al.: Delay of transfer from the intensive care unit: a prospective observational study of incidence, causes, and financial impact. Crit Care 2013; 17:R128
24. Bureau of Labor Statistics: CPI Inflation Calculator. http://www.bls.gov/data/inflation_calculator.htm (Last accessed December 2 2015).
25. Olaussen A, Fitzgerald MC, Tan GA, et al.: Cryoprecipitate administration after trauma. Eur J Emerg Med 2015; doi: 10.1097/MEJ.0000000000000259 [Epub ahead of print]
26. Wikkelso A, Lunde J, Johansen M, et al.: Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev 2013; 8:CD008864
27. Pham HP, Sireci AN, Kim CH, et al.: Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure. Clin Appl Thromb Hemost 2014; 20:607–614
28. Pham HP, Muller MC, Williams LA III, et al.: Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy. Transfusion 2016; 56:926–932
29. National Association of Convenience Stores: US Gasoline Infrastructure. National Association of Convenience Stores. http://www.nacsonline.com/images/GasKit/USMap_50transparent.gif (Last accessed January 20 2016).